NovoCure Ltd (NVCR)
14.77
+0.58
(+4.09%)
USD |
NASDAQ |
May 03, 16:00
14.77
0.00 (0.00%)
After-Hours: 20:00
NovoCure Enterprise Value: 1.185B for May 2, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 1.185B |
| May 01, 2024 | 1.029B |
| April 30, 2024 | 975.31M |
| April 29, 2024 | 1.036B |
| April 26, 2024 | 1.018B |
| April 25, 2024 | 974.23M |
| April 24, 2024 | 986.07M |
| April 23, 2024 | 955.40M |
| April 22, 2024 | 931.19M |
| April 19, 2024 | 959.17M |
| April 18, 2024 | 954.86M |
| April 17, 2024 | 954.86M |
| April 16, 2024 | 998.98M |
| April 15, 2024 | 1.027B |
| April 12, 2024 | 1.118B |
| April 11, 2024 | 1.178B |
| April 10, 2024 | 1.231B |
| April 09, 2024 | 1.259B |
| April 08, 2024 | 1.184B |
| April 05, 2024 | 1.137B |
| April 04, 2024 | 1.196B |
| April 03, 2024 | 1.210B |
| April 02, 2024 | 1.207B |
| April 01, 2024 | 1.317B |
| March 28, 2024 | 1.332B |
| Date | Value |
|---|---|
| March 27, 2024 | 1.226B |
| March 26, 2024 | 1.058B |
| March 25, 2024 | 1.072B |
| March 22, 2024 | 1.073B |
| March 21, 2024 | 1.152B |
| March 20, 2024 | 1.118B |
| March 19, 2024 | 1.108B |
| March 18, 2024 | 1.138B |
| March 15, 2024 | 1.155B |
| March 14, 2024 | 1.223B |
| March 13, 2024 | 1.245B |
| March 12, 2024 | 1.296B |
| March 11, 2024 | 1.371B |
| March 08, 2024 | 1.430B |
| March 07, 2024 | 1.510B |
| March 06, 2024 | 1.441B |
| March 05, 2024 | 1.404B |
| March 04, 2024 | 1.418B |
| March 01, 2024 | 1.398B |
| February 29, 2024 | 1.298B |
| February 28, 2024 | 1.374B |
| February 27, 2024 | 1.404B |
| February 26, 2024 | 1.254B |
| February 23, 2024 | 1.288B |
| February 22, 2024 | 1.290B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
836.10M
Minimum
Nov 10 2023
23.02B
Maximum
Jun 23 2021
8.251B
Average
7.579B
Median
Enterprise Value Benchmarks
| AtriCure Inc | 1.030B |
| NeuroMetrix Inc | -9.118M |
| Repligen Corp | 9.096B |
| Teleflex Inc | 10.94B |
| Perspective Therapeutics Inc | 1.008B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -47.08M |
| Revenue (Quarterly) | 133.78M |
| Total Expenses (Quarterly) | 185.50M |
| EPS Diluted (Quarterly) | -0.45 |
| Gross Profit Margin (Quarterly) | 75.67% |
| Profit Margin (Quarterly) | -35.19% |
| Earnings Yield | -13.20% |
| Normalized Earnings Yield | -13.20 |